Tredje Ap Fonden Bristol Myers Squibb CO Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $4.64 Million - $5.27 Million	-96,800 Reduced 36.89%	165,581 $8.98 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $11.7 Million - $14 Million	-241,960 Reduced 47.98%	262,381 $13.5 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $88,513 - $98,972	1,529 Added 0.3%	504,341 $29.3 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $1.62 Million - $1.8 Million	-25,412 Reduced 4.81%	502,812 $32.2 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $1.67 Million - $1.89 Million	25,349 Added 5.04%	528,224 $36.6 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $5.07 Million - $6.01 Million	74,097 Added 17.28%	502,875 $36.2 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $9,475 - $5.6 Million	72,888 Added 20.48%	428,778 $30.5 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $726,200 - $799,800	10,000 Added 2.89%	355,890 $27.4 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $1.97 Million - $2.36 Million	32,000 Added 10.19%	345,890 $25.3 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $454,675 - $530,044	-8,478 Reduced 2.63%	313,890 $19.6 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $4.44 Million - $5.2 Million	75,000 Added 30.32%	322,368 $19.1 Million
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $6.44 Million - $7.53 Million	-117,561 Reduced 32.21%	247,368 $14.5 Million
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $3.53 Million - $5.13 Million	76,048 Added 26.33%	364,929 $19.2 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $3.85 Million - $5.02 Million	78,189 Added 37.11%	288,881 $18.5 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $287,457 - $340,821	6,721 Added 3.3%	210,692 $10.7 Million
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $105,035 - $116,146	2,354 Added 1.17%	203,971 $9.25 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $347,694 - $414,582	7,706 Added 3.97%	201,617 $9.62 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $3.39 Million - $4.39 Million	-69,452 Reduced 26.37%	193,911 $10.1 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $2.98 Million - $3.36 Million	-54,056 Reduced 17.03%	263,363 $16.4 Million
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $3 Million - $3.74 Million	59,381 Added 23.01%	317,419 $17.6 Million
Q1 2018 May 09, 2018	BUY	$59.92 - $68.98 $99,347 - $114,368	1,658 Added 0.65%	258,038 $16.3 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $14.2 Million - $16.3 Million	256,380	256,380 $16.3 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account